← Human Trials & Peer-Reviewed Studies
Effectiveness of zinc supplementation plus oral rehydration salts compared with oral rehydration salts alone as a treatment for acute diarrhea in a primary care setting: a cluster randomized trial.
Plain-language guide to PMID 18450870 (2008): randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 30,000 people.
Key Facts
- PMID
- 18450870
- Journal
- Pediatrics
- Year
- 2008
- Study type
- Randomized Controlled Trial
- Authors
- Bhandari N et al. (9 authors)
- DOI
- 10.1542/peds.2007-1939
- Registered trial
- NCT00278746
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial looks at Vitamin D, K2, Magnesium and Zinc.
Who Took Part
The study group was 30,000 people.
The age groups tagged for this paper are infants and young children.
Government and private providers and village health workers were trained to prescribe zinc and oral rehydration salts for use in diarrheal episodes in 1-month-old to 5-year-old children in intervention communities; in the control sites, oral rehydration salts alone was promoted.
In 2 cross-sectional surveys commencing 3 months (survey 2) and 6 months (survey 3) after the start of the intervention, care-seeking behavior, drug therapy, and oral rehydration salts use during diarrhea, diarrheal and respiratory morbidity, and hospitalization rates were measured.
How the Study Was Run
The researchers set it up as a randomized study.
Random assignment meant chance, not the researchers, decided who got Vitamin D, K2, Magnesium and Zinc and who got the comparison, which limits bias.
Six clusters of 30,000 people each in Haryana, India, were randomly assigned to intervention and control sites.
What Was Measured
The subject headings attached to it are Caregivers, Developing Countries, Diarrhea, Diarrhea, Infantile, Hospitalization, India and Rehydration Solutions.
What This Means in Plain Language
The paper is a randomized study of Vitamin D, K2, Magnesium and Zinc in 30,000 people.
With several hundred people or more, it is a fairly large study for this kind of research.
Results are reported in around 6 sentences of the abstract; we leave them to the paper itself rather than summarise them.
The publication is from 2008 (Pediatrics), a journal based in United States.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.